Inhibitor of Differentiation 1 (ID1) Facilitates the Efficacy of Sorafenib in Non-Small Cell Lung Cancer Cells through Suppressing Epithelial to Mesenchymal Transition

Related articles

16 May 2022 : Review article

A Review of the Role of the Antiplatelet Drug Ticagrelor in the Management of Acute Coronary Syndrome, Acute Thrombotic Disease, and Other Diseases

Luyuan Tao, Shijia Ren, [...] Li Zhang, Wenhua Liu, Yi Zhao, Changgong Chen, Xiang Mao, Zili Chen, Xingjian Gu - Show fewer authors

DOI: 10.12659/MSM.935664

19 Apr 2020 : Clinical Research

Influence of Hypertension on the Survival of Non-Small Cell Lung Cancer Patients with Type 2 Diabetes Mellitus

Xianghua Zeng, Dong Zeng, [...] Jianan Cheng, Cheng Xu, Chengdu Sun, Haixia Long, Bo Zhu - Show fewer authors

DOI: 10.12659/MSM.921676

04 May 2020 : Animal Research

Effective Chemotherapy of Lung Cancer Using Bovine Serum Albumin-Coated Hydroxyapatite Nanoparticles

Gongzhuo Li, Dongxin Tang, [...] Dingxue Wang, Chuan Xu, Di Liu - Show fewer authors

DOI: 10.12659/MSM.919716

09 May 2020 : Clinical Research

CircPSMC3 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Cells via miR-182-5p/NME2 Axis

Tao Xu, Yejun Yu, [...] Shengcong Guo, Lixiang He, Zejun Mao - Show fewer authors

DOI: 10.12659/MSM.924134

02 Jun 2020 : Clinical Research

Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study

Xiaoli Zhai, Yuehong Guo, [...] Xiaojun Qian - Show fewer authors

DOI: 10.12659/MSM.922675

13 Jul 2020 : Database Analysis

Prediction of Specific Subtypes and Common Markers of Non-Small Cell Lung Cancer Based on Competing Endogenous RNA Network

Yao Liu, Hao Wang, [...] Wenhan Yang, Youhui Qian - Show fewer authors

DOI: 10.12659/MSM.922280

20 Mar 2019 : Clinical Research

Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma

Zhenli Guo, Ju Zhang, [...] Lulu Fan, Jiatao Liu, Hanqing Yu, Xiaoqiu Li, Guoping Sun - Show fewer authors

DOI: 10.12659/MSM.915541

23 May 2019 : Clinical Research

Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland

Melania Brzozowska, Waldemar Wierzba, [...] Sylwia Szafraniec-Buryło, Marcin Czech, Joanna Połowinczak-Przybyłek, Piotr Potemski, Andrzej Śliwczyński - Show fewer authors

DOI: 10.12659/MSM.914517

01 Jun 2019 : Laboratory Research

Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib

Rui Zhang, Zhi Chen, [...] Shu-Sheng Wu, Jun Xu, Ling-Chun Kong, Pei Wei - Show fewer authors

DOI: 10.12659/MSM.914060

25 Sep 2019 : Laboratory Research

Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2

Guanghui Wang, Wei Zhao, [...] Huxia Wang, Guanglin Qiu, Zhengdong Jiang, Guangbing Wei, Xuqi Li - Show fewer authors

DOI: 10.12659/MSM.919219

30 Nov 2018 : Laboratory Research

Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway

Xianping Dai, Feng Geng, [...] Jiale Dai, Mengshun Li, Ming Liu - Show fewer authors

DOI: 10.12659/MSM.911394

20 Jun 2015 : Clinical Research

Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy

Jian-feng Zheng, Juan Lu, [...] Xiao-zhong Wang, Wu-hua Guo, Ji-xiang Zhang - Show fewer authors

DOI: 10.12659/MSM.894669

18 Oct 2015 : Meta-Analysis

Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis

Guangchao Cao, Xiaoyun Li, [...] Chao Qin, Jie Li - Show fewer authors

DOI: 10.12659/MSM.894617